A
Axsome Therapeutics, Inc. (AXSM)
NGM – Real vaqt narxi. Valyuta: USD
156.35
-7.91 (-4.82%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
155.50
-0.85 (-0.54%)
Bozordan keyin: Mar 27, 2026, 7:21 PM EDT

NGM – Real vaqt narxi. Valyuta: USD
156.35
-7.91 (-4.82%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
155.50
-0.85 (-0.54%)
Bozordan keyin: Mar 27, 2026, 7:21 PM EDT
This stock has a consensus price target of $201.95 based on the ratings of 22 analysts. The high is $260.00 and the low is $143.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 143 | $ 201.95 | $ 260 |
| O’zgarish | -8.54% | 29.17% | 66.29% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-25 | 56.7% | Guggenheim | $220 → $245 | Maintains | Buy |
| 2026-02-24 | 60.54% | UBS | $248 → $251 | Maintains | Buy |
| 2026-02-24 | 40.71% | Guggenheim | $205 → $220 | Maintains | Buy |
| 2026-02-24 | 41.99% | RBC Capital | $219 → $222 | Maintains | Outperform |
| 2026-02-24 | 29.2% | Wells Fargo | $193 → $202 | Maintains | Overweight |